If your attention span is modern-media-limited, this one slide is informative:

Check out slides 128-173 from our R&D day and you'll see that genetic discovery and validation are a cornerstone to programs in the clinic or about to enter clinic.

t.co/UFXtSAy4yq

Thanks for the summary and perspective! I have a feeling "some new nightmare" may be a recurring theme for awhile...

If you care about citation stats (which you shouldn't) the fact that every author is more likely to cite their own papers in future work makes the citation stat ROI for adding authors quite good. Big consortia papers dominate citation indices for this reason.

Kitty riding a dolphin is about as informative for biology as genetic correlations 😀

It's not that it's for the rich, but for those with leverage to negotiate it. Seeing this a lot now, even in biotech.

I was in denial initially when people explained to me how profit making practices could be worse at academic medical centers, and undermine cost conscious but high quality care. Disclaimer: I'm on the "for profit" side now, but feel more aligned with actually bringing patients new therapies.

in part because their chief financial officers have to worry about their bond ratings. (Perhaps also because they have boards filled with bankers rather than health care professionals and patients.) And the easiest way to increase your revenues is by becoming a monopoly."

Mercy of Gods was great, looking forward to the next in the series.

How it Unfolds in Audible has ok narrating, not as good a fit as the Expanse series narration.

I started following you when I transferred contacts from my X account over, then you posted this, and now 80% of my "discover" feed is cats... :D